Therapy-related myeloid neoplasms: pathobiology and clinical characteristics
about
Therapy-related myeloid neoplasms - what have we learned so far?Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs'Acute myeloid leukemia: a comprehensive review and 2016 update'Frequency of acute myeloid leukaemia-associated mouse chromosome 2 deletions in X-ray exposed immature haematopoietic progenitors and stem cells.Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X.Overexpression of primary microRNA 221/222 in acute myeloid leukemia.Therapy-related myeloid neoplasms following treatment with radioiodine.Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia.Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP.Radiotherapy- and chemotherapy-induced myelodysplasia syndrome: a nationwide population-based nested case-control study.Live cell detection of chromosome 2 deletion and Sfpi1/PU1 loss in radiation-induced mouse acute myeloid leukaemiaDNA damage and repair in human cancer: molecular mechanisms and contribution to therapy-related leukemias.Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.Therapy-related myelodysplastic syndrome.Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia.Chronic myelogenous leukemia after postoperative adjuvant S-1 therapy for rectal cancer: a case report.Acute myeloid leukemia with TP53 germ line mutations.Fulminant onset of acute leukemia from normal hematopoiesis within 3 months of follow up for multiple myeloma treated with total therapy protocols.10th anniversary of the Austrian MDS Platform: aims and ongoing projects.MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.Role of Circular RNA DLEU2 in Human Acute Myeloid LeukemiaReduced-intensity allografting in patients with therapy-related myeloid neoplasms and active primary malignanciesMutagenic assessment of chemotherapy and Smac mimetic drugs in cells with defective DNA damage response pathways
P2860
Q28071318-03BF05B2-EF91-4C82-A5E0-EB59B7FE6992Q28071427-47D66E62-F021-4E51-84F9-7A908F0D6FADQ28072539-33A295F5-96F3-456D-BEEE-158D988E9686Q33637691-F86FE36C-EEBF-4F93-95B5-2FA21E9CAE2EQ34427193-C4FA7641-AC62-4C6F-BF43-9A1646E811A9Q34877897-86F1A8CA-1129-4F37-AF35-9EC6997BF572Q35717790-81447FB2-4FD7-4A9E-BE14-EDA97D76CC11Q35717852-3395A787-E51F-4FD1-BCFF-5657DBFF9F5FQ36022862-9F1C4364-5EE0-48E3-B349-FF3B97D36B87Q36153838-F226A2E1-6199-4B54-90AA-E930B5DB679EQ37177007-80C39720-AD88-46E7-8FFD-75480320D4D6Q38052129-360F6248-1C55-4BB9-B718-C51B188D29D3Q38093037-56766E5B-7438-4353-803A-D378E0316CE0Q38353167-C6339C5B-AEAB-4A30-80EF-4553EC128A5FQ38984169-4ECEB858-4BFD-41C4-9186-A9ADD0E38059Q39386021-35D6AF95-ACE8-49C7-8A15-7562C7E633A0Q42027206-A49068A5-92D9-4B1E-846A-1E66B64B0FD7Q42374212-9895DD72-6160-4284-9576-9BD096F1F99FQ42679067-87996C34-95F7-4251-B52A-98F5A531449AQ48059034-E86CADCD-B5CE-49E3-A247-55FAE680C073Q48104779-F820A1A6-7CB5-45E0-82D6-53D069D2CC5BQ57469873-F522775C-616D-44CF-9269-7A3F8A2D91BCQ57636771-29FD92DC-33DA-47DE-B69D-FC52F1432446Q58695632-7AC9BB4F-1607-4990-B7F6-B8D58ADD32E2
P2860
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics
@ast
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics
@en
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics
@nl
type
label
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics
@ast
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics
@en
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics
@nl
prefLabel
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics
@ast
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics
@en
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics
@nl
P2093
P2860
P3181
P1476
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics
@en
P2093
P2860
P304
P3181
P356
10.1111/J.1476-5381.2010.01100.X
P407
P577
2011-02-01T00:00:00Z